Synlogic and Ginkgo Bioworks Announce Investigational Artificial Biotic Drugs for the Treatment method of Homocystinuria
CAMBRIDGE, Mass. and BOSTON, Nov. 9, 2021 /PRNewswire/ -- Synlogic, Inc. (Nasdaq: SYBX), a scientific-stage organization bringing the transformative prospective of artificial biology to medicine, and...